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Abstract
Introduction: The Risk, Injury, Failure, Loss, and End-Stage Renal Disease (RIFLE) is a consensus-based classification
system for diagnosing acute kidney insufficiency (AKI), based on serum creatinine (SCr) and urine output criteria
(RIFLESCr+UO). The urine output criteria, however, are frequently discarded and many studies in the literature applied
only the SCr criteria (RIFLESCr). We diagnosed AKI using both RIFLE methods and compared the effects on time to
AKI diagnosis, AKI incidence and AKI severity.
Methods: This was a prospective observational cohort study during four months in adult critically ill patients
admitted to the ICU for at least 48 hours. During the first week patients were scored daily for AKI according to
RIFLESCr+UO and RIFLESCr. We assessed urine output hourly and fluid balance daily. The baseline SCr was estimated if
a recent pre-ICU admission SCr was unknown. Based on the two RIFLE methods for each patient we determined
time to AKI diagnosis (AKI-0) and maximum RIFLE grade.
Results: We studied 260 patients. A pre-ICU admission SCr was available in 101 (39%) patients. The two RIFLE
methods resulted in statistically significantly different outcomes for incidence of AKI, diagnosis of AKI for individual
patients, distribution of AKI-0 and distribution of the maximum RIFLE grade. Discarding the RIFLE urine criteria for
AKI diagnosis significantly underestimated the presence and grade of AKI on admission and during the first ICU
week (P < 0,001) and significantly delayed the diagnosis of AKI (P < 0.001). Based on RIFLESCr 45 patients had no
AKI on admission but subsequently developed AKI. In 24 of these patients (53%) AKI would have been diagnosed
at least one day earlier if the RIFLE urine criteria had been applied. Mortality rate in the AKI population was 38%
based on RIFLESCr and 24% based on RIFLESCr+UO (P = 0.02).
Conclusions: The use of RIFLE without the urine criteria significantly underscores the incidence and grade of AKI,
significantly delays the diagnosis of AKI and is associated with higher mortality.
Introduction
Acute kidney injury (AKI) is a common clinical syndrome
in the intensive care unit (ICU) and associated with an
increase in morbidity, mortality and length of stay [1]. The
Risk, Injury, Failure, Loss and End-Stage Renal Disease
(RIFLE) classification system developed in 2004 by the
Acute Dialysis Quality Initiative (ADQI) [2,3] is a consen-
sus definition for the diagnosis of AKI. The severity grades
risk, injury and failure are defined on the basis of the
changes in serum creatinine (SCr) or urine output where
the worse of each criterion is used (Table 1). If a reliable
baseline SCr is unknown, ADQI suggests the calculation
of a theoretical baseline value by the modification of diet
in renal disease (MDRD) equation [4]. RIFLE is the first
widely accepted AKI definition, validated in over half a
million patients worldwide [5-7]; however, the urine cri-
teria are frequently discarded [8-16]. Notably, transient
oliguria occur frequently in ICU patients and its use often
identifies a higher percentage of AKI patients compared to
SCr alone [17-19].
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We hypothesized that discarding the urine criteria not
only decreases the estimated incidence of AKI but also
increases the time to AKI diagnosis.
We determined the time to reach AKI diagnosis (AKI-0)
in a heterogeneous ICU population admitted to the ICU
for more than 48 hours using both RIFLE methods (with
and without urine output). Additionally, we assessed the
impact of these two RIFLE methods on the incidence and
grading of AKI.
Materials and methods
Study design and setting
We performed anonymous analysis of routinely collected
clinical data. The Medical Ethics Review Committee of
our institution waived the need for informed consent.
The study was carried out between April 2009 and
August 2009 in the ICU of the Academic Medical Center,
a major university hospital in Amsterdam with a 28-bed
general, multidisciplinary closed format ICU. During the
study period all patients receiving ICU treatment for
more than 48 hours were eligible for enrolment. Patients
with known end-stage renal disease or receiving renal
replacement therapy were excluded.
Data collection
Demographic data, clinical history (including the lowest
documented SCr within six months of ICU admission),
and severity of illness were recorded on ICU admission.
For each patient the lowest documented SCr within six
months of hospital admission was recorded (pre-ICU
admission SCr). The estimated SCr baseline was calculated
from the MDRD equation assuming a GFR of 75 ml/min/
1.73 m2 (MDRD75) [4]. Urine output was measured hourly
by visual readings of the amount of urine accumulated in
a urine metre. Fluid balance, SCr and the presence of
renal replacement therapy (RRT) were documented daily.
We did not record details of type of fluid administration,
use of diuretics and other medications.
Assessment of acute kidney injury
During the first seven days of ICU treatment patients
were scored daily for AKI based on RIFLE using SCr and
urine output criteria (RIFLESCr+UO) and based on the
RIFLE SCr criteria only (RIFLESCr). The lesser of pre-ICU
admission SCr and ICU admission SCr served as baseline
renal function. If pre-ICU admission SCr was unknown
the baseline was taken as the minimum between the
MDRD75 based and ICU admission SCr [20].
For each patient we determined the number of days
elapsed until AKI was first diagnosed (AKI-0) according
to the two RIFLE methods. In addition, we classified
patients into four grades according to their maximum
RIFLE grade: no AKI, risk, injury and failure. Patients
receiving RRT therapy were classified as having failure.
Statistical analysis
Statistical analyses were performed in the statistical envir-
onment R version 2.10.1 (R Foundation for Statistical
Computing, Vienna, Austria) [21] and we used the “boot”
library for performing the bootstrap procedures. Data are
presented as number and percentage, mean ± SD, or med-
ian and quartiles. The baseline characteristics of the
patients with and without a pre-ICU admission baseline
SCr were compared using the t-test (for normally distribu-
ted quantities) or the Mann-Whitney U-test and the pro-
portion test (for proportions). We tested differences
between the two RIFLE methods for the following
outcomes:
a) Difference in the distribution of first day on which
AKI was diagnosed
b) Difference in the distribution of the maximum
RIFLE grade
To measure the differences in the distributions a) and
b), we calculated the 95% confidence interval (CI) around
the two-sample Kolmogorov-Smirnov D statistic and the
P-value associated with the null-hypothesis that D = 0,
that is, that there are no differences between the methods
for the two distributions. To obtain D’s 95% CI we used
the standard bootstrap procedure [22] with 3,000 boot-
strap samples. A bootstrap sample has the same size as
the original dataset and is obtained by random re-sam-
pling, with replacement, from the original dataset. To
obtain P-values for D we use a permutation test in which
we construct 3,000 permutation re-samples and calculate
the proportion of times in which the Kolmogorov-Smir-
nov statistic for the permutation was larger than D.
c) Difference in incidence of AKI and AKI associated
mortality
Table 1 Risk, Injury, Failure, Loss and End-stage Kidney (RIFLE) classification [2]
Class Serum creatinine criteria Urine output criteria
Risk ↑ SCr ≥1.5 × from baseline <0.5 ml/kg/h ≥6 h
Injury ↑ SCr ≥2 × from baseline <0.5 ml/kg/h ≥12 h
Failure ↑ SCr ≥3 × from baseline or an acute ↑ SCr ≥44 μmol/l from baseline SCr ≥354 μmol/l <0.3 ml/kg/h ≥24 h or anuria ≥12 h
Loss Complete loss of kidney function >4 weeks
End-stage End-stage kidney disease >3 months
Only one criterion (serum creatinine or urine output) has to be fulfilled to qualify for a specific stage. SCr, serum creatinine
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To determine the difference in AKI incidence, that is,
having or developing AKI in the first seven days of hos-
pital stay, we again used the basic bootstrap procedure
with 3,000 samples [22]. This allowed us to obtain the
incidence and variance of AKI in the whole sample in
the first seven days of the hospital stay. To test the dif-
ference in mortality rate we used the proportion test.
d) Difference in diagnosis of AKI in individual patients
To test differences in concordance between RIFLE
methods in diagnosing AKI in individual patients we used
the McNemar test. The following example illustrates the
difference between incidence of AKI in a sample and AKI
diagnosis in individual patients: if method M1 diagnoses
three patients as “AKI”, “non-AKI” and “AKI”, and method
M2 diagnoses these same patients as “AKI”, “AKI” and
“non-AKI” respectively, then the incidence of AKI in both
methods is equal (two out of three), but the individual
diagnoses are different for the second (non-AKI, AKI) and
third (AKI, non-AKI) patient. The diagnoses are hence
concordant only in the first patient.
e) Difference in fluid balances
To test differences in fluid balance in patients classified
according to both RIFLE methods, we calculated fluid
balance both on the first day of AKI diagnosis and cumu-
lative (from ICU admission up to the first day of AKI
diagnosis). For comparison we used the Mann-Whitney
U-test.




During the study period 260 patients were treated in the
ICU for at least 48 hours. The demographic data are
shown in Table 2. Pre-ICU admission SCr level was avail-
able in 101 (39%) and estimated in 159 patients (61%). In
the patients with a known prior renal function the differ-
ence between pre-ICU admission SCr and estimated base-
line SCr was not statistically significant (90 ± 34 μmol/L
versus 88 ± 12 μmol/L, P = 0.39); however, pre-ICU admis-
sion SCr was significantly lower than SCr on ICU admis-
sion (90 ± 34 μmol/L versus 125 ± 121 μmol/L, P < 0.01).
A total of 38 out of 101 patients (38%) had a lower SCr on
ICU admission compared to their pre-ICU level (76 ± 40
μmol/L versus 92 ± 38 μmol/L, P < 0.0001). In the patients
without a known pre-ICU admission SCr the difference
between estimated baseline SCr and SCr on ICU admission
was statistically significant (88 ± 12 μmol/L versus 107 ±
69 μmol/L, P < 0.001). A total of 81 out of 159 (51%)
patients had a significantly lower SCr on ICU admission
compared to their estimated baseline SCr (64 ± 15 μmol/L
versus 90 ± 13 μmol/L, P < 0.0001). In the patients with a
known pre-ICU admission SCr, the lower of pre-ICU
admission and ICU-admission SCr served as the baseline





Unknown pre-ICU admission SCr
(n = 159)
P-value
Age (years) 60 ± 16 64 ± 13 58 ± 17 <0.01
Men (%) 62 65 60 NS
Weight (kg) 83 ± 22 81 ± 22 84 ± 22 NS
APACHE II 21 ± 8 21 ± 7 21 ± 9 NS
SAPS 52 ± 17 54 ± 16 50 ± 17 NS
Type of admission (%)
Medical 56 50 61 NS
Surgical urgent 27 22 30 NS
Surgical elective 17 28 9 <0.01
Baseline SCr (μmol/l)
Pre-ICU admission - 90 ± 34 unknown
Admission 115 ± 93 125 ± 121 107 ± 69 NS
Estimated2) 88 ± 12 88 ± 12 88 ± 13 NS
ICU mortality (%) 21 19 22 NS
ICU stay (days) 7.0 (5.0 to 12.0) 7.0 (4.25 to 10.75) 8.0 (5.0 to 13.5) NS
Comorbidity (%)
Hypertension 30 34 27 NS
Diabetes mellitus 17 22 14 NS
Chronic Renal Failure1) 6 10 4 NS
Cardiovascular disease 33 39 30 NS
Values are mean ± SD, median (quartiles) or percentage of patients. APACHE, Acute Physiology and Chronic Health Evaluation; GFR, glomerular filtration rate;
SAPS, Simplified Acute Physiology Score; SCr, serum creatinine. 1) GFR <45 ml/min, based on pre-ICU admission morbid SCr and MDRD equation [4]. 2) Based on
the MDRD equation assuming a GFR of 75 ml/min/1.73 m2 [4].
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for RIFLE, while in the patients without a known pre-ICU
admission, the lower of the estimated SCr and ICU admis-
sion SCr served as baseline for RIFLE. Therefore, pre-ICU
admission SCr served as baseline for RIFLE in 63 (24%)
patients, ICU admission served as baseline for RIFLE in
120 (46%) patients and estimated SCr served as baseline
for RIFLE in 77 (30%) patients. Patients with a known pre-
ICU admission SCr were statistically significantly older and
were more frequently surgical patients than patients with-
out a known pre-ICU admission SCr.
a) Difference in the distribution of first day on which
AKI was diagnosed
Figure 1 compares the distribution of timing of AKI-0
based on the two RIFLE methods. The difference between
the two methods was statistically significant D = 0.39, 95%
CI 0.33 to 0.45, P < 0.0001. On admission, 116 (45%)
patients had AKI based on RIFLESCr+UO, while based on
RIFLESCr, only 63 (24%) had AKI. Based on RIFLESCr,
45 patients had no AKI on admission but subsequently
developed AKI within seven days of ICU stay. In 24 of
these patients (53%), AKI would have been diagnosed at
least one day earlier if the RIFLE urine criteria had been
applied (Figure 2). During the first ICU week, 102 (39%)
patients were diagnosed with AKI based on a reduction in
urine output (RIFLESC+UO), but without a rise in SCr, and
thus were not diagnosed with RIFLESCr: 38 (15%) patients
on admission; 33 patients (13%) on Day 1; 18 (7%) patients
on Day 2; 7 (3%) patients on Day 3; 2 (0.8%) patients on
Day 4; and 4 (1.5%) patients on Day 5. In 9 (9%) of these
patients CVVH was started before a rise in SCr and 8 (8%)
patients died without reaching the RIFLESCr criteria. Urine
output recovered after one or more days in the remaining
85 (83%) patients.
b) Difference in the distribution of the maximum
RIFLE grade
Figure 3 compares the two distributions of the maxi-
mum RIFLE grade during the first ICU week. The 95% CI
around the Kolmogorov-Smirnov D statistic and asso-
ciated P-value D = 0.39, 95% CI 0.33 to 0.45, P < 0.0001
show that one method resulted in a significantly different
Figure 1 Distribution of first day on which AKI was diagnosed
according to two RIFLE methods. RIFLESCr+UO, based on serum
creatinine and urine criteria; RIFLESCr, based on serum creatinine
criteria only.
Figure 2 Time benefit of RIFLESCR+UO in patients primarily
diagnosed using RIFLESCr
Figure 3 Distribution of the maximum RIFLE grade and
associated mortality based on two RIFLE methods. RIFLESCR+UO,
based on serum creatinine and urine criteria; RIFLESCr, based on
serum creatinine criteria only.
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distribution than the other method. RIFLESCr classified
102 (39%) patients more as having no AKI in the first
week of ICU-stay comparing to RIFLESCr+UO. Those
patients according to RIFLESCr+UO had: AKI-risk 46 (18%)
patients, AKI-injury 49 (19%) patients and AKI-failure
7 (3%) patients.
c) Difference in incidence of AKI and AKI-associated
mortality
The incidence of AKI in the first ICU week was 42%
(95% CI: 36 to 48%), (108 patients) based on RIFLESCr ver-
sus 81% (95% CI: 76 to 86%), (210 patients) based on
RIFLESCr+UO. 95% CI around the difference between two
RIFLE methods on AKI incidence (-0.45 to 0.33) shows
that the differences were statistically significant, as the CI
does not include 0. More non-surviving patients were AKI
positive according to RIFLESCr+UO (N = 51) than RIFLESCr
(N = 41); however, the relative mortality rate was signifi-
cantly higher by RIFLESCr than RIFLESCr+UO (38% versus
24%, P = 0.02)
In Figure 3 we presented mortality rates in patients
within each RIFLE severity grade.
d) Difference in diagnosis of AKI in individual patients
The difference in diagnosing AKI by the two RIFLE
methods is statistically significant (P < 0.0001).
e) Difference in fluid balances
The daily fluid balance was calculated using 24-hour
fluid intake and output. Based on RIFLESCr+UO, 210
patients were diagnosed with AKI of which 174 (83%)
patients had a positive fluid balance on AKI-0. Based on
RIFLESCr, 108 patients were diagnosed with AKI of
which 174 (90%) had a positive fluid balance on AKI-0.
Table 3 shows the 24 hours fluid balance on the first
day of AKI diagnosis (AKI-0) as well as the cumulative
fluid balance defined as the sum of the daily fluid bal-
ances from ICU admission up to and including AKI-0.
f) Continuous veno-venous hemofiltration (CVVH)
Forty-nine patients received CVVH treatment during
the first ICU week. The majority of patients (82%) started
CVVH within the first three days of ICU admission: 14
patients on ICU admission, 13 patients on Day 1, 13
patients on Day 2, 4 patients on Day 3, 1 patient on Day 4,
2 patients on Day 5 and 2 patients on Day 6. Table 4
shows the maximum RIFLE score before the initiation of
CVVH based on the two RIFLE methods. Based on
RIFLESCr+UO, all patients had Injury or Failure at the start
of CVVH, while based on RIFLESCr, 22 (45%) patients had
Injury or Failure, 9 (18%) patients had no AKI and 8 (16%)
patients had Risk. The difference between the two RIFLE
methods was statistically significant (D = 0.35, 95% CI
0.20 to 0.40, P < 0.0001). In seven patients (14%), CVVH
was started based on an increased SCr (Injury or Failure)
while urine output was not decreased.
On ICU admission, 14 patients started with CVVH
and were, therefore, scored as ‘Failure’. Table 5 shows
the maximal RIFLE grade on admission based exclu-
sively on SCr and urine output, and not on the presence
of CVVH.
Discussion
The RIFLE classification is the first widely accepted defini-
tion for AKI; however, many studies have applied RIFLE
incorrectly without the use of urine output [7]. We per-
formed a prospective observational study and compared
AKI diagnosis based on RIFLESCr+UO with that based on
RIFLESCr. The two RIFLE methods resulted in statistically
significantly different outcomes for incidence of AKI, diag-
nosis of AKI for individual patients, time to diagnosis of
AKI and maximum RIFLE grade. Discarding the RIFLE
urine output criteria for AKI diagnosis significantly under-
estimated the presence of AKI on admission and during
the first ICU week (P < 0.001), and significantly delayed
the diagnosis of AKI (P < 0.001). In our study, the use of
RIFLESCr instead of RIFLESCr+UO resulted in fewer patients
diagnosed with mild AKI (AKI-risk and AKI-injury) and
more patients having no AKI. A total of 102 (39%) patients
never had AKI during the first ICU week according to
RIFLESCr, while these patients were indeed diagnosed as
having AKI based on RIFLESCr+UO. The question arises of
whether at least some of the oliguric patients without an
increase in SCr actually did have AKI, or whether they
Table 3 Daily and cumulative fluid balance on first day of AKI diagnosis
AKI-0 AKI based on RIFLESCr AKI based on RIFLESCr+UO
Daily1) Cumulative2) Daily1) Cumulative2)
Day 0 1,617(620 to 3,348) 1,617(620 to 3,348) 2,217(707 to 3,522) 2,217(707 to 3,522)
Day 1 3,308(1,985 to 5,615) 5,499 *(3,271 to 8,605) 2,581(1,097 to 3,653) 3,587 *(1,287 to 5,588)
Day 2 3,605 *(1,400 to 6,077) 10,547 *(6,565 to 13,796) 981.5 *(81 to 3,196) 4,238 *(1,170 to 7,757)
Day 3 3,353 *(2,106 to 3,532) 13,723 *(13,413 to 17,128) -528 *(-840 to -96) 4,950 *(2,706 to 5,463)
Day 4 2,137(1,056 to 2,724) 7,965(6,459 to 8,892) 742(372 to 1,563) 5,167.5(1,564 to 8,429)
Day 5 -537.5(-933 to -142) -495(-509 to -481) -546(-1,328 to -457) 204(-467 to 3,280)
Day 6 885(548 to 1,222) -3,732.5(-6,022 to -1,443) 885(548 to 1,222) -3,732.5(-6,022 to -1,443)
*Statistical significance P < 0.05. Values are medians (quartiles); AKI, acute kidney injury; AKI-0, First day of AKI diagnosis, RIFLESCr, RIFLE serum creatinine criteria
only; RIFLESCr+UO, RIFLE serum creatinine and urine output criteria.
1)Daily fluid balance, fluid balance on first day of AKI-diagnosis; 2)Cumulative fluid balance,
cumulative fluid balance from ICU admission up to the first day of AKI diagnosis.
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were oliguric for some other reason (for example, their
hydration status) [23,24]. In our patients, AKI-0 was diag-
nosed based on a decrease in urine output without a rise
in SCr in 132 (51%) patients. In 9 (7%) of these patients
CVVH was subsequently started before a rise in SCr while
in 24 patients (18%) SCr rose in the next one to three days
reaching the RIFLESCr criteria. Eight (6%) had persistent
oliguria and died without a rise in SCr and 91 (69%)
patients recovered and never reached the RIFLESCr Risk
criteria. The majority (83%) of patients diagnosed with
AKI based on RIFLESCr+UO had positive fluid balances on
the day AKI was diagnosed.
These findings suggest that for mild AKI the patient’s
urine output criterion does not match well with the
patient’s respective creatinine criterion. Our findings con-
firm prior observations [19,25]. In the small (N = 75)
prospective observational study by Macedo et al., 28%
of patients were diagnosed with AKI based on the SCr
criteria only, in comparison to 55% when using only
the urine output criteria [25]. In the recent multicentre
observational study by Prowle et al., AKI diagnosis based
on SCr was infrequent, while oliguria was relatively com-
mon [19].
In the present study, the applied RIFLE method also
affected the time to diagnosis of AKI. In comparison with
RIFLESCr+UO, the use of RIFLESCr increased the time to
AKI diagnosis and resulted in fewer patients with AKI on
admission: 210 (81%) patients had AKI during the first
week of ICU according to RIFLESCr+UO while only 108
(42%) patients had AKI according to RIFLESCr. Of note,
on the day of ICU admission 63 (24%) patients had AKI
according to RIFLESCr while 116 (45%) patients had AKI
according to RIFLESCr+UO. According to RIFLESCr, 45
patients developed AKI after ICU admission and in 53%
of these patients AKI would have been diagnosed at least
one day earlier based on the RIFLE urine criteria. Our
findings are congruent with the recent prospective study
by Macedo et al. in 317 critically ill surgical patients,
showing that oliguria diagnosed AKI earlier in compari-
son with the SCr criterion [26].
Our findings are not surprising. Different definitions
lead to different answers. An important factor is why most
studies did not apply the recommended consensus urine
output criteria [3]. The catalyst for the changes in SCr in
the consensus definition came from Chertow’s paper: a
solid statistical argument [27]. In contrast, the urine out-
put criteria arrived via expert opinion; however, there is
always the possibility that it is wrong. In addition, measur-
ing urine output is tedious and it is still unclear how the
hourly criteria should be applied (continuously or for each
six-hour period of the day), with or without diuretics.
Many studies omitted the urine criteria because they ret-
rospectively applied the RIFLE criteria to existing data-
bases that did not capture either any urine output criteria
or only captured urine output data in a form that cannot
be applied. The big question remains - does it really mat-
ter and why? We need to know whether defining AKI with
or without including urine output actually leads to a dif-
ference in AKI-outcome associations. In the present study,
ICU mortality in patients with AKI was significantly higher
when AKI was diagnosed by RIFLESCr (38%) compared to
that based on RIFLESCr+UO (24%). Similar differences are
also suggested by two large multicenter epidemiologic stu-
dies by Hoste et al. (AKI based on RIFLESCr+UO) and
Uchino et al. (AKI based on RIFLESCr) [16,20]. In these
two studies, baseline mortality in non-AKI patients was
comparable; however, mortality in the AKI-risk, -injury
and -failure group was much higher in the cohort studied
by Uchino et al., despite the fact that the latter was a hos-
pital-wide population and the former a general ICU popu-
lation [16,20]. Similarly, the systematic review by Ricci et
al. showed that the relative risk for death among studies
that used RIFLESCr+UO was lower than in those using
RIFLESCr [6]. In the present study, mortality in the Risk
and Injury groups was higher when AKI was based on
RIFLESCr, while in the Failure group mortality was higher
when AKI was based on RIFLESCr+UO. AKI-associated
mortality, however, was not part of our primary hypothesis
and the small number of patients in each RIFLE stratum
keep us from any conclusions.
Table 4 RIFLE scores at the start of continuous veno-venous
hemofiltration (number of patients and percentage)
RIFLESCr RIFLESCr+UO*
No AKI 9 (18%) 0
Risk 8 (16%) 0
Injury 13 (27%) 16 (33%)
Failure 19 (39%) 33 (67%)
Total 49 (100%) 49 (100%)
*The difference between the two RIFLE methods is statistically significant (D =
0.35, 95% CI 0.20 to 0.40, P < 0.0001). RIFLESCr, RIFLE diagnosis based on RIFLE
serum creatinine criteria only; RIFLESCr+UO, RIFLE diagnosis based on both
serum creatinine and urine criteria; No AKI, patients without any occurrence of
RIFLE criteria.
Table 5 RIFLE scores on the first ICU admission day
(number of patients and percentage).
RIFLESCr RIFLESCr+UO
No AKI 200 (77%) 144 (55%)
Risk 29 (11%) 54 (21%)
Injury 14 (5%) 36 (14%)
Failure1) 17 (7%) 26 (10%)
Total 260 (100%) 260 (100%)
CVVH 14 (5%) 14 (5%)
CVVH, continuous veno-venous hemofiltration; No AKI, patients without any
occurrence of RIFLE criteria; RIFLESCr, RIFLE diagnosis based on RIFLE serum
creatinine criteria only; RIFLESCr+UO, RIFLE diagnosis based on both serum
creatinine and urine criteria. 1) Based on serum creatinine and urine criteria
only, the initiation of CVVH not taken into account.
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In addition to its effect on AKI-associated mortality,
the nonuse of the urine criterion may also influence the
diagnostic accuracy of new biomarkers for AKI, including
neutrophil gelatinase-associated lipocalin (NGAL) and
cystatin C [11,28-31]. Serum cystatin C was found to be a
good predictor for AKI (without urine criteria) in the
study by Herget-Rosenthal [11], while cystatin C was a
poor predictor for AKI (with urine criteria) in the study
by Royakkers et al. [31]. In addition to case mix, the
opposite findings of both studies may also be caused by
the application of two different RIFLE methods (with and
without urine output criteria).
To apply the SCr criteria of RIFLE information on prior
renal function is needed. When a pre-ICU admission SCr
is not available, ADQI suggest that the baseline SCr be
estimated from the MDRD formula [2]. Zavada et al.
showed that estimating baseline SCr may over- or under-
estimate AKI [32]; however, in another study by Bagshaw
et al. [33], estimating baseline by the MDRD equation
appeared to perform reasonably well for determining the
RIFLE categories as long as the pre-ICU admission GFR
was near normal. In our study, a pre-ICU admission SCr
was available in 101 (39%) patients and in these patients
the difference between pre-ICU SCr and estimated SCr
was not statistically significant (90 ± 34 μmol/L versus
88 ± 12 μmol/L, P = 0.39. However, SCr level on ICU
admission was significantly higher than the pre-ICU
admission SCr (125 ± 121 μmol/L versus 90 ± 34 μmol/L,
P < 0.01). Of note, in the present study, 81 (51%) out
of the 159 patients with an unknown prior SCr had lower
SCr at ICU admission compared with the estimated SCr.
Although this issue is not discussed by the ADQI, in these
patients we used the lower SCr level as suggested by
Hoste et al. [20].
In the present study patients receiving CVVH were clas-
sified as Failure as suggested by the acute kidney injury
network (AKIN) [3]; however, in the original RIFLE sys-
tem introduced by the ADQI, renal replacement therapy
was not included as a distinct stage [2]. Indeed, it may be
questionable to classify patients as Failure if they did not
achieve the specific RIFLE score. In our study, using
RIFLESCr+UO, 67% of the patients had Failure and 33% had
Injury at the start of CVVH. In contrast, using RIFLESCr,
only 39% of the patients had Failure, 27% had Injury, 16%
had Risk and 18% had no AKI. Given the variability in the
timing of renal replacement therapy worldwide, it may be
more appropriate to always report the AKI stage at the
start of renal replacement therapy in future epidemiologic
studies.
Our study is the first study comparing the effects of two
RIFLE methods (with and without urine output criteria)
on time to AKI diagnosis as well as AKI incidence, AKI
associated mortality and maximum AKI grade. We, how-
ever, recognize the limitations of our study. First, our
study is single-centre, including a limited number of
patients. Second, SCr was measured daily, while urine
output was measured hourly. More frequent SCr measure-
ments may result in earlier detection of AKI. Third,
although we recorded fluid status, we did not evaluate
whether our patients received diuretics. However,
although the use of diuretics is common practice world-
wide, their use is not explicitly addressed in the RIFLE
criteria. Fourth, we did not correct SCr for hemodilution.
A positive fluid balance may cause dilution of SCr and,
therefore, a delay in the diagnosis based on RIFLESCr [18].
Two studies showed that hemodilution of SCr may affect
AKI diagnosis [18,34]. The basis for the development of
the RIFLE classification, however, was Chertow’s paper
[27] showing that a small rise in SCr increased mortality,
and this paper did not correct for hemodilution. In addi-
tion, estimating the dilution factor in critically ill patients
is notoriously difficult. Fifth, we did not specifically evalu-
ate patients with chronic kidney disease because this
subgroup was too small in our sample. Last, our results
were statistically significant; however, future research will
need to study the clinical significance in more detail.
Conclusions
Although the RIFLE classification is meant to provide a
uniform AKI definition, at least two RIFLE methods
(with and without urine output criteria) are used in the
literature. In the present study, comparison of the two
methods showed statistically significant differences in
time to diagnosis of AKI, AKI incidence, AKI associated
mortality and maximum AKI grade. Discarding the urine
output criteria delayed the diagnosis of AKI, decreased
the incidence of AKI diagnosis and was associated with
higher mortality.
Our findings suggest that, even when the ‘consensus’
RIFLE definition is used, the methods employed for esti-
mating AKI need to be robustly reported, and that most
already published AKI retrospective epidemiological
studies may, therefore, be inaccurate.
Key messages
Use of RIFLE without the urine criteria significantly:
• underscores the incidence of AKI,
• underscores severity of AKI,
• delays the diagnosis of AKI,
• is associated with higher mortality
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